Presentation is loading. Please wait.

Presentation is loading. Please wait.

Lung Cancer Presentation Dr Richard Sullivan and Ms Anne Fraser 6 th November 2014.

Similar presentations


Presentation on theme: "Lung Cancer Presentation Dr Richard Sullivan and Ms Anne Fraser 6 th November 2014."— Presentation transcript:

1 Lung Cancer Presentation Dr Richard Sullivan and Ms Anne Fraser 6 th November 2014

2 2 Overview Background Risk Profile of Lung Cancer The Lung Cancer Pathway Treatment and Management DHB Contacts Q & A

3 6 September Background Lung cancer is the leading cause of cancer deaths in New Zealand –1942 people diagnosed in 2010 –1650 people died in 2010 Survival in NZ is poorer than Australia, Canada, the USA & some European countries

4 4 Background Poor survival in lung cancer is because the majority of lung cancer patients present with advanced incurable disease 5yr survival (NSCLC) : Stage I/II 50%, III 15%, IV <3% Differences in survival between countries relate to management Earlier diagnosis of people with lung cancer has the potential to improve survival, when combined with appropriate and timely investigation and treatment Initial Presentation –76% Patients presented to primary care –24% Patients presented to secondary care 14% self-presented to the Emergency Department (ED) 10% were already under secondary care when they developed symptoms or had an incidental finding ( Stevens, W et al - Final Report - Identification of barriers to the early diagnosis of people with lung cancer and description of best practice solutions July 2012)

5 5 Background Significant health inequalities exist: Maori & Pacific have poorer lung cancer survival outcomes –Maori patients are approximately 3 times more likely to die from their lung cancer than non-Maori patients Known differences in stage of disease at diagnosis –Maori patients were 2.5 times more likely to have locally advanced disease Known differences in management of disease –Maori patients had longer timelines from diagnosis to treatment

6 6 Background Prevention and Awareness –Social marketing – “Cough, Cough, Cough” –Tobacco Control/Smoking Cessation –NRT, buproprion (Zyban), varenicline (Champix) –Access to support and counselling NZ National efforts –Aspire 2025, plain packaging

7 7 Background Why don’t we screen for lung cancer? "screening with annual CT has been shown to reduce lung cancer deaths compared to chest Xray” ……. BUT high number needed to screen best selection criteria for screening not yet known cost effectiveness uncertain risk of over diagnosis and invasive tests for benign disease need for lots of follow up CTs Also smoking cessation and tobacco control are likely to be much more (cost) effective

8 8 Risk Profile Cigarettes Lung Cancer Emphysema/COPD

9 9 Profile of a Patient that should be Referred urgently for a chest x-ray Unexplained haemoptysis OR Any of the following unexplained, persistent (lasting more than 3 weeks or less than 3 weeks in people with known risk factors) symptoms and signs: –Chest and/or shoulder pain –Shortness of breath –Weight loss/loss of appetite –Abnormal chest signs –Hoarseness –Finger clubbing –Cervical and/or supraclavicular lymphadenopathy –Cough –Features suggestive of metastasis from a lung cancer (e.g., in brain, bone, liver or skin) (NZ Guidelines Group)

10 10 Profile of a Patient that should be Referred Urgently to a Specialist Persistent haemoptysis and are smokers or ex- smokers aged 40 years or older A chest x-ray suggestive of lung cancer (including pleural effusion and slowly resolving consolidation) Finger clubbing Severe weight loss SVC Obstruction Neck nodes – in smokers (NZ Guidelines Group)

11 11 Includes diagnostics, surgical & non- surgical treatments All cancers by tumour stream Lung Cancer Pathway CT Lung cancer Primary Care

12 6 September Identification of Barriers to the Early Diagnosis of Lung Cancer and Description of Best Practice Solutions Principal Investigator: Dr Wendy Stevens Cancer Trials New Zealand, the University of Auckland Funded by a Health Research Council of New Zealand & District Health Boards New Zealand Grant

13 13 1.Presentation/Attendance Barriers 2.Identification Barriers 3.Waiting Time Barriers 4.Information Barriers Our Barriers to Early Diagnosis

14 14 Best Practice Solutions TO REDUCE BARRIERS WITHIN PRIMARY CARE 1.Increase awareness of lung cancer in primary care 2.Smoking status routinely recorded 3.Improve GP utilisation of CXRs 4.Follow up systems in place for patients 5.Regionally consistent investigation & referral pathways 6.A standardised template for e-referral system 7.Audit tool for the assessment of GP lung cancer referral

15 15 Northern Region Radiological Referral Processes ADHB and CMDHB –Access to Diagnostics Tool using community and hospital service providers –Utilising e-referrals process –Some practices utilising Fax refferal system NDHB –GP refers to hospital respiratory services with suspected cancer –Respiratory service has to refer for CT scan –Future planned implementation of macro e-referral template WDHB –Utilising e-referrals in some practices –Utilise current Fax referral system

16 16 Radiology Access Chest x-rays –E-referral or Fax CXR or CT –All DHBs have radiology liaisons that can be called to discuss needs and gain access –Patients can been seen same/next day –GP practices will receive a report with next steps All Significant findings will include a phone call to GP If CT required this should be sent at the same time as FSA –GPs should be confident in ability to access good DHB radiology capacity

17 17 Lung cancer Pathway Respiratory High Suspicion Lung Cancer When there is a high suspicion of cancer – ensure that you complete Referral to Respiratory Referral to CT

18 18 Advances in Treatment/Management Management –Minimally invasive staging and surgery Endobronchial ultrasound Thoracoscopic resections –Stereotactic radiotherapy Less toxic to normal lung –Targeted chemotherapy More effective if +ve for mutations; oral tablets –Advanced Care Planning and Palliative care

19 19 Key Take Home Messages (1) Prevent lung cancer –Ask about smoking status; offer support to quit Recognition of lung cancer –Smokers with emphysema/COPD at highest risk –Persistent cough (longer than 3 weeks) not responding to treatment – most common symptom –Low threshold for ordering Chest Xray –Consider ordering CT chest at same time as specialist referral –DHBs are now required to see and treat your patient quickly; most are already doing so

20 20 Key Take Home Messages (2) Help treat lung cancer –Advanced Care Planning –Help to give excellent quality palliative care – it can improve quality of life and even survival Lung cancer is not hopeless –Co-morbid patients may still be able to have minimally invasive surgery or modern radiotherapy –Targeted chemotherapy is effective, less toxic and easier to take in suitable patients –Palliative radiotherapy is effective for symptom control

21 21 ADHB Key Contacts Central Referrals Office – fax (09) Respiratory –(09) (Physician roster in place) Radiology - Auckland DHB GP Advice/ Contacts –Hot Desk 8.30am to 4.30pm Monday to Friday (09) Ext 24571# –Fax (09) (Auckland City Hospital) –Fax (09) (Greenlane) –Emergency Phone (09) (GP hotline) Oncology – If under Regional Cancer Service –CNS Anne Fraser – –Medical Ongologist Dr Richard Sullivan –

22 Appendix

23 23 When you click on Help  Referral Guidelines

24 24 Useful Website Guide


Download ppt "Lung Cancer Presentation Dr Richard Sullivan and Ms Anne Fraser 6 th November 2014."

Similar presentations


Ads by Google